🇺🇸 FDA
Patent

US 12122815

GIP receptor agonist peptide compounds and uses thereof

granted A61KA61K38/00A61K47/02

Quick answer

US patent 12122815 (GIP receptor agonist peptide compounds and uses thereof) held by Takeda Pharmaceutical Company Limited expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K38/00, A61K47/02, A61K9/0019, A61K9/08